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Equilibrium constantsBacterial bioﬁlm formation causes a range of problems in our society, especially in health care. Salicylidene
acylhydrazides (hydrazones) are promising antivirulence drugs targeting secretion systems used during bacterial
infection of host cells. When mixed with the gallium ion they become especially potent as bacterial and bioﬁlm
growth-suppressing agents, although themechanisms throughwhich this occurs are not fully understood. At the
base of this uncertainty lies the nature of hydrazone–metal interactions. This study addresses this issue by resolv-
ing the equilibrium speciation of hydrazone–gallium aqueous solutions. The protonation constants of the target
2-oxo-2-[N-(2,4,6-trihydroxy-benzylidene)-hydrazino]-acetamide (ME0163) hydrazone species and of its 2,4,6-
trihydroxybenzaldehyde and oxamic acid hydrazide building blockswere determined byUV–visible spectropho-
tometry to achieve this goal. These studies show that the hydrazone is an excessively strong complexing agent for
gallium and that its antivirulence properties are predominantly ascribed to monomeric 1:1 Ga–ME0163 com-
plexes of various Ga hydrolysis andME0163 protonation states. The chelation of Ga(III) to the hydrazone also in-
creased the stability of the compounds against acid-induced hydrolysis, making this group of compounds very
interesting for biological applications where the Fe-antagonist action of both Ga(III) and the hydrazone can be
combined for enhanced biological effect.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
As traditional antibiotics are becoming increasingly inefﬁcient, new
approaches in treating bacterial infections are needed. Drugs that target
virulence factors are one of such routes, disabling pathogens to infect a
host and cause disease. Anti-virulence drugswould protect fromdisease
by disarming but not killing the pathogen. Such a strategy attenuates
the selective pressure for development of drug resistance compared to
biocides [1]. Salicylidene acylhydrazides—known as hydrazones—are
highly promising anti-virulence components, inhibiting type III secre-
tion system in a range of Gram-negative bacteria [2] without killing
them. Although virulence-inhibiting mechanisms of hydrazones are
largely unknown, recent studies are pointing to multiple targets in the
bacterial cell [2,3].
The hypothesis of hydrazone binding to the trivalent Fe(III) and
Ga(III) ions has also received much attention in the literature due to
its possible work in depleting the solution of bioavailable Fe [4–9].
In order to compare the chelating efﬁciency of hydrazones and
siderophores, equilibrium constants are very important. Unfortunately,46 90 786 7655.
46 90 786 7655.
.-F. Boily),
. This is an open access article undervery little thermodynamic data exists on hydrazone–metal ion afﬁnity,
thus impeding the advancement of knowledge in this area. In a study
by Richardson et al., three acidity constants (pKa) were obtained for a
substance of similar structure (Fig. 1b). They found three pKa values of
3.43 (pyridyl nitrogen), 8.29 (sole hydroxyl group on benzyl ring) and
9.8 (the_N\NH\ hydrogen of the hydrazone motif) [7]. In the pres-
ence of Fe this ligand (L) was found to form four Fe complexes with
overall formation constants (log βpqr) of log β−1,1,1 = 38.3 (FeHL2+),
log β−2,1,2 = 48.8 (Fe(HL)2+), log β−3,1,2 = 54 (Fe(HL)L0) and log
β−4,1,2 = 56 (FeL2−). These formation constants would result in a free
Fe concentration of 10−50M (i.e.− log[Fe3+]= pFe= 50) in a solution
with pH 7.4, [Fe(III)]=10−6M and [L]=10−3•M[8], showing that this
groupof substances can be very strong Fe chelators, in fact stronger than
many bacterial siderophores (e.g. enterobactin result in pFe = 38 and
desferrioxamin B (DFOB) pFe = 28, pyoverdin pFe = 28 under similar
conditions [8,10]) aswell asmammalian Fe-binding proteins transferrin
and lactoferrin. However, protonation and binding to metal ions can
vary between molecules in the hydrazone family due to substituents
in the molecule [7,8,11], giving rise to differences in hydrophilicity
and lipophilicity [11] or electron distribution [12].
Restriction of iron to bacteria can also be achieved through the use of
Ga(III), an Fe(III) mimetic that is taken up into the bacterial cells via
Fe(III) uptake routes using bacterial siderophores [13]. Ga(III) can inhib-
it bioﬁlm formation and growth especially for bacteria with highthe CC BY license (http://creativecommons.org/licenses/by/3.0/).
b)
a)
Fig. 1. a) Synthesis of ligand 2-oxo-2-[N-(2,4,6-trihydroxy-benzylidene)-hydrazino]-
acetamide (ME0163 or L) from the 2,4,6-trihydroxybenzaldehyde (THB) and oxamic
acid hydrazide (OAH). Arrows show protonation sites (here neutral forms of substances
are shown). b) Hydrazone in Richardson et al. [7,8].
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by being incorporated into bacterial metabolic systems that demand
iron and, subsequently, disrupting them [16]. Additionally, chelation
with gallium ions [12,17,18] has been shown to enhance the effect of
hydrazones that target Fe metabolism in tumors and was proposed as
candidates for anti-cancer drugs [19,20] suggesting that the same could
be true for effects on bacterial cells. These ﬁndings are thereby calling
for an understanding of the nature of hydrazone–gallium interactions in
aqueous solutions, which is the object of this study. The equilibrium sta-
bility constants of hydrazone–gallium complexes were determined for
the ME0163 ligand (Fig. 1a), a complex that in a parallel study was
found to have high anti-bioﬁlm and anti-virulence properties [21]. The
speciation of the ligand and Ga(III) complex was resolved by UV–visible
(UV–VIS) spectrophotometric measurements of solutions at various
Ga(III):ligand ratios, in part due to the low solubility of this ligand. A che-
mometric treatment of the resulting spectral sets was used to extract sta-
bility constants for its protonation constants and gallium-binding
constants. These efforts also extracted molar absorption coefﬁcients that
can be used to identify various hydrazone species in subsequent studies.2. Methods
2.1. Chemicals
Chemicals were purchased from Sigma-Aldrich and used without
puriﬁcation unless otherwise stated. The 2-oxo-2-[N-(2,4,6-trihydroxy-
benzylidene)-hydrazino]-acetamide (ME0163) hydrazone was synthe-
sized (Fig. 1) by a method described elsewhere [2] using 2,4,6-
trihydroxybenzaldehyde (THB) (Aldrich) and oxamic acid hydrazide
(OAH) (Acros Organics) as parent building blocks. The molecular struc-
ture of ligand ME0163 used in this study was conﬁrmed NMR. All solu-
tions were prepared from deionized and boiled water (resistance =
18.2 MΩ) at an ionic strength of 0.1 M NaCl (Merck p.a., dried at453K). A 30mMHCl solution in 0.1MNaClwasmade fromconcentrated
HCl (37% Aldrich) and standardized against tris(hydroxymethyl)
aminomethane (Trizma base). A 10 mM NaOH solution in 0.1 mM NaCl
(degassed with N2(g)) was made from a 50% NaOH solution and stan-
dardized against the standardized HCl solution. A 10.6mM Ga(NO3)3 so-
lution was prepared from Ga(NO3)3·xH2O (Aldrich) in 0.1 M NaCl and
40.5 mM NaOH, giving gallium in the form of the soluble Ga(OH)4− ion.
The exact concentration of Ga(III) ions was determined by using Atom
Absorption Spectrometry (Perkin Elmer AAS 3110).
2.2. NMR
NMR analyses at low pH 1.5–4.0 were carried out using a Bruker
(400 MHz) NMR spectrometer in D2O:H2O (~99:1). The samples
(~1 mM) were prepared by adding 10 mMNaOH solution into the solu-
tion of ME163 ligand (L) in 0.1 M NaCl, and pH was adjusted by 30 mM
HCl. In case of the Ga(III)–L system, 10.6 mM Ga(OH)4− solution was
also added. The samples were equilibrated overnight (~16 h).
2.3. UV–VIS spectrophotometric titrations
Protonation constants of the parent 2,4,6-trihydroxybenzaldehyde
(THB), parent oxamic acid hydrazide (OAH), and synthetic ME0163
hydrazone species were determined by UV–VIS spectrophotometric ti-
trations [22–24]. Ga(III)-binding constants to ME0163 were also deter-
mined using the same method. Due to the low solubility of hydrazones
and the sensitivity range in the UV–VIS spectrophotometer, very dilute
solutions of [L] = 0.034–0.063 mM and [Ga] = 0.052–0.074 mM were
used. Experiments were done with ratios L:Ga = 1:1.2 and 1:1.3. The
concentrations were determined by careful gravimetric measurements
of dry hydrazone before dissolution into a well-determined volume of
ionic medium. The concentrations were double checked using a calibra-
tion curve made by diluting a solution at relatively high concentration
(1.35mM) and creating a calibration curve fromUV–VIS spectra. Concen-
tration range for the calibration curve was 0.07–0.02 mM. More detailed
description for the titrations can be found in supplementary information.
2.4. Speciation calculations
Experimental data obtained from potentiometric titration and UV–
VIS measurements were used for thermodynamic and spectrophoto-
metric predictions of the speciation of the THB, OAH and ME0163 li-
gands (HsL, where s is 3, 1 and 4 respectively). Mass action equations
are expressed for the L complexes as:
HsþpLr
p⇌pHþ þ rHsL ð1Þ
where Ka · [Hs + pLr] p = [HsL0]r · [H+]p and for Ga(III)–H4L with:
pHþ þ qGa3þ þ rH4L⇌Gaq H4Lð Þr Hð Þp3qþp ð2Þ
where [Gaq (H4L)r (H)p]3q + p = βp,q,r · [H+]p · [Ga3+]q · [H4L0]r
Mass balance equations are:
Ga½ Tot ¼
Xp
0
Xq
0
Xr
0
q Gaq H4Lð Þr Hð Þp
h i3qþp ð3Þ
L½ Tot
Xp
0
Xq
0
Xr
0
r Gaq H4Lð Þr Hð Þp
h i3qþp ð4Þ
H½ Tot ¼
Xp
0
Xq
0
Xr
0
p Gaq H4Lð Þr Hð Þp
h i3qþp þ Hþ
h i
−K−1w H
þh i−1 ð5Þ
In these expressions, p, q and r are stoichiometric coefﬁcients. The
chloride and sodium ion mass balances were not considered in the
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dium. Description of how spectrophotometric data were related to the
thermodynamic models can be found in supplementary information.
Molar absorption coefﬁcients and stability constants were ﬁrst de-
termined for the building block THB and OAH molecules. These values
were then used in the evaluation of the stability constants of ME0163
to address possible spectral contributions from the building blocks
appearing by hydrolytic cleavage at low pH whereby:
ME0163þ H2OþHþ⇌THB0 þHOAHþ ð6Þ
Possibilities for gallium-oxyhydroxide precipitation were also taken
into account in the modeling procedure by determining the total galli-
um solubility in the ME0163-bearing system.
2.5. Molecular modeling
Lowest energy conformers as well as pKa values of ME0163 and
both parent compounds were identiﬁed using MarvinSketch 6.1.3
(ChemAxon [26]). Energy calculations were carried out using the
Merck Molecular Force Field 94 (MMFF94), using very strict optimiza-
tion limits deﬁned by the program. Molecular energies were calculated
for all possible protonation conﬁgurations; pKa values were predicted
using macro mode and dynamic acid/base preﬁx.
3. Results and discussion
3.1. Protonation of ME0163 and of its parent compounds
Aprerequisite to determining gallium–ME0163 binding strength en-
tails knowledge of the stability ﬁeld of the ligand as well as its proton-
ation constants. Potential protonation sites for the parent compounds
and the ligand are indicated in Fig. 1a. pKa values for these protonation
sites (Table 1) were ﬁrst estimated using MarvinSketch 6.1.3 to guide
interpretations of experimental data. Protonation constants of hydroxyl
groups (7.48 ortho, 8.98 ortho, 10.3 para) and amino groups (2.25
NH\NH3+, 10.2 CO\NH) for parent compounds are somewhat compa-
rable to those of the ME0163 ligand (8.54, 9.72, 10.7 for ortho-, ortho-,
para-hydroxyl groups; 11.3 for the N\NH bridge).
In an effort to facilitate the experimental determination of pKa
values of ME0163, the protonation constants of the three phenolic OH
groups of the parent THB molecule were ﬁrst determined. The UV–VIS
spectra of THB are characterized by strong π–π⁎ transitions involvingTable 1
Equilibrium constants for Gaq(H4L)r(H)p3q + p describing the protonation of starting
materials (2,4,6-trihydroxybenzaldehyde (THB) and oxamic acid hydrazide (OAH)),
ligand ME0163 and Ga(III)–ME0163 complex in solutions at 25 °C and I = 100 mM.
Systems p,q,r Products logβ p,q,r, pKa's from exp/theory
THB (H3L) 1,0,1a H2L1− −5.6 5.6/7.48
2,0,1a HL2− −13.2 7.6/8.98
3,0,1a L3− −22.8 9.6/10.3
OAH (HL) 1,0,1a L1− −10.1 10.1/10.2
−1,0,1a H2L+ -/2.25
ME0163 (H4L) 1,0,1a H3L1− −6.8 6.8/8.54
2,0,1a H2L2− −14.5 7.7/9.72
3,0,1a HL3− −25.1 10.6/10.7
4,0,1a L4− - -/11.3
HC c HOAH++THB 1.2
Ga(III)–ME0163 −3,1,1 b [Ga(OH)2H3L]0 32.8
−4,1,1b [Ga(OH)3H3L]1− 29.4
−6,1,1b [Ga(OH)3HL]3− 16.1
a Stoichiometric coefﬁcients for the protonation of the ligands (Eq. (1)).
b Stoichiometric coefﬁcients for Ga–ME0163 complexation (Eq. (2)).
c Constant for hydrolytic cleavage (Eq. (6)). The hydrolysis constants for Ga3+ are [25]:
log β −1,1,0 = −3.93; log β −2,1,0 = −7.73; log β −3,1,0 = −12.38; log β−4,1,0 =
−15.96; log β−32,13,0 = −66.3; log β−3,1,0(s) = −3.54.phenyl ring p-orbitals aswell as charge-transfer-to-solvent (CTTS) tran-
sitions of the basic phenolic oxygen lone pairs hydrogen-bonded to sol-
vent water molecules (Fig. 2a). A strong peak at 320 nm in alkaline
solutions gradually attenuates with acidity and ultimately gives rise to
a predominant peak at 290 nm in acidic solutions. A singular value de-
composition (SVD)-based dimensional analysis points to the contribu-
tion of 4 linearly-independent components describing the variance in
the absorbance data, corresponding to the THB3−, THB2−, THB1− and
THB0 species. Extraction of the stability constants and molar absorption
coefﬁcients of these species using the method described in Section 2.3
gave the equilibrium constants pKa1 = 9.6, pKa2 = 7.6, and pKa3 =
5.6, and fully described the experimental data (Fig. 2b and Table 1).
These values were lower than the predicted values. The resulting
molar absorption coefﬁcients show that the ﬁrst two protonation
steps correspond to considerable attenuations of the 320 nm peak,
while the last with a strong blue shift to 290 nm. This last shift thus cor-
responds to the formation of a neutrally-charged species, and thus to
decreased CTTS transitions undergone by the charged species at the
lower energy 320 nm peak.
The same exercise was repeated for the OAH building block of
ME0163 (Fig. 2c and d). The lower level of conjugation in this molecule
gives rise to less complexUV–VIS spectra, shifted towards higher energy
values. In this case, a peak at 275nmbecomes largely attenuated by pro-
tonation, leaving a faint shoulder at 250 nm of superimposed on stron-
ger portion of a peak gaining importance atwavelengths below 226 nm.
All data can be ﬁt by two species related by the pKa1 = 10.1, one that it
associated to the protonation of the basic N group of this molecule. The
corresponding OAH− species has thus a strong discernable peak at
275 nmdue to CTTS transitions involving theN lone pair, which then at-
tenuates in OAH0. This pKa agreed well with the predicted pKa value.
However, the additional protonation step predicted at low pH could
not be resolved experimentally.
TheME0163 ligand exhibits comparable traits to THB, except that its
lowest energy peak is ~47 nm lower (Fig. 3). This effect is the possible
result of the increased electron delocalization in the ME0163 coupled
with its greater charge. The 380 nm peak undergoes a strong attenua-
tion with protonation, blue-shifting by ~47 nm to 333 nm by pH 5.1
then ultimately to ~290 nm at pH 3.1, just as in THB. Given possible
complications arising from the hydrolytic cleavage of CH_N in aqueous
solution, producing the original parent molecules, UV–VIS and NMR
spectra were ﬁrst surveyed over a broad range of solution conditions.
These efforts notably showed that the ligand did decompose at
pH below ~3.7, as can be seen by the disappearance of \CH_N\
(8.36 ppm) and concomitant appearance of \CH_O moiety
(9.90 ppm) below this value in NMR spectra (Fig. 4). Spectrophotomet-
ric titrations also showed that this reaction was reversible, and could be
described as a proton-promoted hydrolytic cleavage of ME0163 to the
THB0 and the protonated form of OAH0, as described in Eq. (6).
Having identiﬁed the pH stability ﬁelds of the ME0163 ligand, the
corresponding spectrophotometric data were used to extract proton-
ation constants for this ligand. A dimensionality analysis pointed to
ﬁve linearly-independent components. One of these components corre-
sponds to THB0, with a peak at 290 nmwhile the one from OAH0 could
not be clearly elucidated given its relatively low intensities. The remain-
ing four components thereby correspond to three protonation steps in
ME0163. Extraction of proton-promoted hydrolytic cleavage (KHC) and
protonation constants was carried out using molar absorption coefﬁ-
cients of the parent molecules as hard constraints. Best-ﬁtting proton-
ation constants (Table 1) are comparable to those of the parent THB
species, suggesting that the ﬁrst (pKa1 (H4L) = 6.8; pKa2(H3L) = 7.7)
correspond to the deprotonation of phenolic groups. The third depro-
tonation may originate from the remaining phenolic group or the
N\NH bridge, and based on the pKa predictionswe assign it to the phe-
nol in para- position. Note that distinct protonation constant for the last
protonation step could not be extracted from the data as it is expected at
pH N11. The assignment is also supported by molecular energy
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Fig. 2. a and c) Spectrophotometric titrations of a) THB in 0.1MNaCl at 25 °C in the pH 9.3–3.2 range and c)OAH in 0.1MNaCl at 25 °C in the pH 10.0–3.3 range. Red arrows show changes
in spectral intensity with decreasing pH. Red lines show deviations of ﬁt of themodel to the data (black lines). b and d)Molar adsorption coefﬁcients of the four species responsible for the
data of a) and c) respectively and related with the pKa values of Table 1.
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detailed in Section 3.4 and the predicted pKa values (Table 1). As for the
THB starting material the experimentally determined pKa values for
the OH groups in the ligand were lower than the predicted ones.
While these values are different to those reported by Richardson on a
similar substance (experimental: hydroxyl pKa = 8.3 and N-NH bridge
pKa = 9.8, predicted: hydroxyl pKa = 8.7 and N-NH bridge pKa = 9.9)
[7], our ﬁndings may arise from the high level of conjugation in
ME0163, and withdrawing electron density from the N base (Fig. 1).
Based on the equilibrium constants obtained, H4L0, H3L1− and H2L2−
are the dominant species in the 3–10 pH range. Themodel also predicts
signiﬁcant levels of hydrolytic cleavage to the parent THB and OAH
compounds from the fully protonated H4L0 species under acidic condi-
tions only.3.2. Ga(III)–ME0163 complexation
A survey of the Ga(III)-bearing solutions over a broad range of pH
values was carried out to determine the stability ﬁeld of ME0163. In
contrast to the pure ligand system, ligand decomposition takes place
at pH values below3 (Fig. 5), thus suggesting that Ga(III)–ME0163 com-
plexation stabilizes the ligand against hydrolytic cleavage. We also note
that Ga(III) increased the solubility of the ligand, two ﬁrst observations
pointing to signiﬁcant Ga(III)–ME0163 complexation. A third comes
from the enhanced Ga(III) solubility, seen through the absence of any
turbidity in the solutions through the lack of light scattering that
would have otherwise occurred by colloidal galliumhydroxide particles
in the 400–800 nm region at circumneutral pH.
Ga(III)–ME0163 complexation was studied in solutions of Ga(III)
(0.05–0.07mM) andME0163 (0.04–0.06mM) (Fig. 6a and b). A dimen-
sionality analysis of the spectra revealed that eight orthogonalcomponents were required to ﬁt the two sets of experimental absor-
bance data. Emphasizing that none of the soluble gallium hydroxide
complexes contribute to the absorbance data and that we have identi-
ﬁed ﬁve ME0163 species in the previous section, three additional spe-
cies should be invoked to reproduce the variance of the data. Various
species combinations of systematically varied p, q, and r in the complex
Gaq(H4L)r(H)p were tested for their ability to reproduce the absorption
matrix, one that was evaluated based on SOS = Σ(Acalc − Aexp)2.
The best-ﬁtting combination of species describing the spectrophoto-
metric titration data consists of [Ga(OH)2H3L]0 (p, q, r = −3,1,1),
[Ga(OH)3H3L]1−(p, q, r = −4,1,1) and [Ga(OH)3HL]3− (p, q, r =
−6,1,1). It therefore only consisted of 1:1 Ga:ME0163 complexes of dif-
ferent protonation states. We note that the molar absorption coefﬁ-
cients of (−3,1,1) and (−4,1,1) are highly similar, and blue-shifted by
about 25 nm from those of the (−6,1,1) species are. They are therefore
likely to arise from ligands of the same protonation state but gallium
ions of different hydrolysis state. Furthermore, we considered the pro-
tonation steps of the pure ligand system and the hydrolysis of Ga(III)
in the absence of ligand. Thus, assignment of (−6,1,1) best corresponds
to the [Ga(OH)3HL]3− species, while (−4,1,1) to [Ga(OH)3H3L]1− and
(−3,1,1) to [Ga(OH)2H3L]0. The corresponding equilibrium reactions
for the formation of these three complexes (with log β values in
Table 1) are given below:
β−3;1;1 Ga
3þ þ H4L þ 2H2O⇌ Ga OHð Þ2H3L
 0 þ 3Hþ ð7Þ
β−4;1;1 Ga
3þ þ H4L þ 3H2O⇌ Ga OHð Þ3H3L
 − þ 4Hþ ð8Þ
β−6;1;1 Ga
3þ þ H4L þ 3H2O⇌ Ga OHð Þ3HL
 3− þ 6Hþ ð9Þ
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physiological pH the solution predominantly consists of a mixture of
the [Ga(OH)3HL]3− and [Ga(OH)3H3L]1− complexes. As for the pure li-
gand system, the two deprotonation steps of H3L− to form HL3− were
very close in pH, and could not be separated for the complex. At high
pH, the ligand is not complexed and Ga is predominantly in the form
of gallate (Ga(OH)4−1). Taking these observations together suggests
that Ga(III) should bind in the chelatingmotive through the azomethine
nitrogen, the carbonyl and one phenolic group. Stated otherwise, it is
forming both a 5-, and a 6-membered chelate with various moieties of
ME0163. These interactions are thus reducing the electron density at
the azomethine C\H and N, and thus explaining the downward shift
in the NMR spectra from 8.36 ppm in ME0163 to 8.87 ppm in mixed
Ga:ME0163 solutions. Finally, we note that these speciﬁc interactionsare the cause for the greater resilience of ME0163 against the hydrolytic
cleavage of CH_N, and hence the persistence of this ligand over a great-
er range of pH values in the presence of gallium.3.3. Implications for the biological use of Ga:ME0163
To compare the Ga(III) chelation of this ligandwith other relevant li-
gands, we compared the free gallium ion concentration in the presence
of ligand (− log[Ga3+] = pGa) at 1 μM Ga3+, 10 μM ligand and pH 7.4.
Ligands that form strong complexes give rise to low free metal ion con-
centrations, i.e. higher pGa. For the hydrazone in this study pGa was
21.3, for DFOB 25.1, EDTA 21.0 and citrate 19.3 (I = 100 mM). The
pGa in water is 18.3 after hydrolysis of Ga3+. This calculation illustrates
that the binding strength of the hydrazone to gallium ions is similar to
the strong chelator EDTA and a little weaker than the siderophore
DFOB that has previously been investigated with Ga(III) for antibac-
terial purposes [13,14]. This comparison suggests that the complex
should be stable in biological media and keep Ga(III) in a soluble bio-
available form. At the same time, since it has a slightly lower afﬁnity
compared to bacterial siderophores such as DFOB, it could be expect-
ed that Ga(III) would be released from the hydrazone in the presence
of siderophores and be taken up into bacterial cells instead of Fe(III)
through the Fe(III) uptake routes. Previous studies have shown that
Ga(III) complexes with ligands with lower pGa than DFOB (citrate
in that study) can more efﬁciently deliver Ga(III) to the bacterial
cells than GaDFOB, presumably since it allows for multiple uptake
routes using several siderophores that all have binding afﬁnities sim-
ilar to that of DFOB [12]. Compared to citrate, the hydrazone in this
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2.3, 2.7, and 3.3. The data point to the hydrolytic cleavage of\CH_N\ of ME0163, pro-
ducing the THB compound at pH b b 2.7, namely ~1 pH unit lower than in the absence
of Ga(III).
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logical pH [12] making it a very interesting candidate for biological
studies.
3.4. Conclusions
In this studywehave characterized the solution chemistry of the gal-
lium hydrazone complex Ga–ME0163 and found that its strength of
complex formation to Ga(III) is close to that of EDTA and only slightly
less than DFOB. The complex formed exhibited enhanced stability at
low pH compared with the pure ligand due to the binding of Ga(III) in
the hydrazone motif blocking the site of acid-induced hydrolysis of
the ligand. This speciation, aswell as the stability of the Ga(III) complex,is of great importance to understand the biological activity of this com-
plex and to be able to predict how its stability can be preserved in differ-
ent types of conditions. Stability issues in the form of hydrolysis of the
hydrazone bond have previously been identiﬁed as a problem for phar-
maceutical usage [9] of these types of substances despite the promising
biological effect and low toxicity proﬁle for many of them. However,
considering that the presence of metal ions such as Ga(III) dramatically
increases the stability of thesemolecules at lowpH, it could beworth re-
examining them as candidates for drugs targeting bacterial virulence
15S. Hakobyan et al. / Journal of Inorganic Biochemistry 138 (2014) 9–15and bioﬁlm formation. Furthermore, since the complex formation be-
tween Ga(III) and the hydrazone is slightly lower than that of Ga-
DFOB it can be expected that the complex would efﬁciently deliver
Ga3+ to the bacterial cells making it a very interesting candidate for an-
tibacterial drugs that would be active in Fe restricted conditions.
Abbreviations
ME0163 2-oxo-2-[N-(2,4,6-trihydroxy-benzylidene)-hydrazino]-
acetamide
L ligand
DFOB desferrioxamin B
THB 2,4,6-trihydroxybenzaldehyde
OAH oxamic acid hydrazide
Ka the acid dissolution constant
β overall formation constant
βpqr overall formation constant for reaction of reactants with stoi-
chiometric coefﬁcients p, q, and r
SOS sum of squares of errors
KHC degradation constant
SVD singular value decomposition
CTTS charge-transfer-to-solvent
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